Cryoablation method and system

Patent metadata

Field	Value
Publication number	US-9956024-B2
Application number	US-201414329571-A
Country	US
Kind code	B2
Filing date	Jul 11, 2014
Priority date	Jul 11, 2014
Publication date	May 1, 2018
Grant date	May 1, 2018

Abstract

A system and method for providing greater control over the temperature of a thermal treatment element of a medical device, enabling an operator to extend a thawing period of a cryoablation procedure. The system may include a fluid flow path that bypasses a subcooler, giving the operator selective control over the temperature of refrigerant delivered to the treatment element and, therefore, treatment element temperature. Additionally or alternatively, the system may include a fluid delivery conduit that is in communication with a liquid refrigerant and a gaseous refrigerant. Adjustment of the ratio of liquid to gaseous refrigerant also offers control over the treatment element temperature. Additionally or alternatively, the system may include one or more valves and/or heating elements in the fluid delivery and recovery conduits to control the treatment element temperature.

First claim

What is claimed is:

1. A system for controllable adjustment of the temperature of a treatment element of a medical device, the system comprising:
a fluid delivery conduit including an upstream portion and a downstream portion;
a subcooler located between the upstream fluid flow path and the downstream fluid flow path;
a bypass fluid flow path having a first end that is in direct communication with the upstream portion of the fluid flow path and a second end that is in direct communication with the downstream portion of the fluid flow path;
a first valve located in the upstream portion of the fluid flow path between the subcooler and the first end of the bypass fluid flow path;
a second valve located in the bypass fluid flow path; and
an operating console including a processor, the processor being programmed to:
circulate a fluid within the treatment element at a first temperature, the first temperature being a temperature at which tissue ablation occurs;
adjust the first valve and the second valve during a thawing phase to increase the temperature of the fluid within the treatment element to a second temperature that is greater than the first temperature; and
then extend the thawing phase of the treatment element by maintaining the fluid within the treatment element at a temperature of between −20° C. and −25° C. for a period of time between two seconds and 40 seconds.

2. The system of claim 1 , further comprising a refrigerant source in fluid communication with the fluid delivery conduit.

3. The system of claim 2 , wherein the treatment element reaches a minimum treatment temperature when the first valve is completely open and the second valve is completely closed.

4. The system of claim 2 , wherein the treatment element reaches a maximum treatment temperature when the first valve is completely closed and the second valve is completely open.

5. The system of claim 2 , wherein the refrigerant source is a liquid refrigerant source, the system further comprising a gaseous refrigerant source in fluid communication with the fluid delivery conduit.

6. The system of claim 5 , wherein adjusting the ratio of gaseous refrigerant to liquid refrigerant selectively controls the temperature of the treatment element.

7. The system of claim 6 , wherein the liquid refrigerant source is a first tank and the gaseous refrigerant source is a second tank.

8. The system of claim 6 , wherein the liquid refrigerant source and the gaseous refrigerant source are a common tank.

9. The system of claim 8 , wherein the common tank defines a fluid reservoir, the liquid refrigerant source being at the bottom of the fluid reservoir and the gaseous refrigerant source being at the top of the fluid reservoir.

10. The system of claim 9 , wherein the common tank includes a first valve in fluid communication with the liquid refrigerant source and a second valve in fluid communication with the gaseous refrigerant source, manipulation of at least one of the first and second valves adjusting the ratio of gaseous refrigerant to liquid refrigerant.

11. The system of claim 10 , wherein the tank further includes a dip stick in communication with the first valve and extending into the liquid refrigerant source.

12. The system of claim 10 , wherein the first and second valves are on the same end of the common tank.

13. The system of claim 10 , wherein the first and second valves are on opposite ends of the common tank.

14. The system of claim 1 , wherein the fluid delivery conduit is in fluid communication with the treatment element, the system further comprising:
a fluid recovery conduit in fluid communication with the treatment element;
a first valve in the fluid recovery conduit; and
a second valve in the fluid delivery conduit,
independent manipulation of at least one of the first and second valves selectively controlling the temperature of the treatment element.

15. The system of claim 1 , wherein the fluid delivery conduit is in fluid communication with the treatment element, the system further comprising:
a fluid recovery conduit in fluid communication with the treatment element; and
a valve in the fluid recovery conduit,
manipulation of the valve selectively controlling the temperature of the treatment element.

Assignees

• Medtronic Cryocath Lp

Inventors

• Mahrouche Rachid
• Wittenberger Dan

Classifications

• A61B2018/00577

  Ablation · CPC title

• A61B2018/00011

  with fluids · CPC title

• A61B2018/0212

  using an instrument inserted into a body lumen, e.g. catheter · CPC title

• A61B2018/00041

  Heating, e.g. defrosting · CPC title

• A61B18/02 Primary

  by cooling, e.g. cryogenic techniques · CPC title